PLAU and breast cancer: We have previously shown that metastatic breast cancer cells (for example, MDA-MB-231) have increased uPA at the cell surface and have the potential to bind and activate relatively large amounts of plg compared to nonmetastatic cells (for example, MCF-7 and T-47D) [27].